Compound ID | 2849
Class: Membrane-active agent
| Agent Type: | Synthetic; Small molecule; Direct acting; Antibiotic adjuvant; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Membrane-active agent. Dissipates proton motive force |
| Target Pathogen: | Active against biofilm and planktonic Acinetobacter baumannii |
| Description: | Decreases bacterial load and increases survival rate of mice infected with Acinetobacter baumannii when in combination with rifampicin; repurposed drug (approved for clinical use to inhibit overproduction of gastric acid); shows synergistic effects with rifampicin, ceftriaxone, gentamicin, and polymyxin B; shows intrinsic antimicrobial activity |
| Institute where first reported: | College of Animal Science and Technology, Jilin Agricultural University, Changchun, China |
| Year first mentioned: | 2023 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/5702160 |
| Citation: | https://journals.asm.org/doi/10.1128/jb.00187-23 |